Global Microbiome Market

Global Microbiome Market Size, Share, Growth Analysis, By Product(Probiotics, Prebiotics), By Application(Therapeutics, Diagnostics), By Distribution Channel(Retail Pharmacies, Online Pharmacies) - Industry Forecast 2024-2031

Report ID: SQMIG35J2043 | Region: Global | Published Date: February, 2024
Pages: 224 | Tables: 92 | Figures: 76

Global Microbiome Market Competitive Landscape

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Microbiome Market Top Player’s Company Profiles

  • Second Genome Inc.
  • Viome Inc.
  • uBiome Inc.
  • Enterome SA
  • Seres Therapeutics Inc.
  • Rebiotix Inc.
  • Vedanta Biosciences Inc.
  • Microbiome Insights Inc.
  • Microbiome Therapeutics LLC
  • Finch Therapeutics Group Inc.
  • BiomX Inc.
  • Synlogic Inc.
  • Immuron Ltd.
  • Axial Biotherapeutics Inc.
  • AOBiome LLC
  • Evelo Biosciences Inc.
  • Diversigen Inc.
  • DayTwo Inc.
  • Biomillenia SAS
  • Caelus Health Inc.

Microbiome Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Microbiome Market size was valued at USD 573.42 billion in 2019 and is poised to grow from USD 743.21 billion in 2023 to USD 5918.61 billion by 2031, growing at a CAGR of 29.61% in the forecast period (2024-2031).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Second Genome Inc.', 'Viome Inc.', 'uBiome Inc.', 'Enterome SA', 'Seres Therapeutics Inc.', 'Rebiotix Inc.', 'Vedanta Biosciences Inc.', 'Microbiome Insights Inc.', 'Microbiome Therapeutics LLC', 'Finch Therapeutics Group Inc.', 'BiomX Inc.', 'Synlogic Inc.', 'Immuron Ltd.', 'Axial Biotherapeutics Inc.', 'AOBiome LLC', 'Evelo Biosciences Inc.', 'Diversigen Inc.', 'DayTwo Inc.', 'Biomillenia SAS', 'Caelus Health Inc.'

Increasing focus on human microbiome therapeutics development

Increasing collaborations between public-private organizations

North America is expected to account for the lion's share of the global human microbiome market. The region's domination is due to the rising prevalence of lifestyle problems and advances in next-generation sequencing. For example, Illumina Inc., a major player in the United States, claims that the introduction of next-generation sequencing enables various high-profile joint projects, like the Human Microbiome Project and MetaHIT. Using Next Generation Sequencing as a basic tool, these projects have published a wide range of data on the human microbiome.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Transthyretin Amyloidosis Treatment Market
Buy Now GET FREE SAMPLE
Bioequivalence Studies Market
Buy Now GET FREE SAMPLE
Pharmaceutical Contract Sales Organizations Market
Buy Now GET FREE SAMPLE
Medical Software Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Microbiome Market

Product ID: SQMIG35J2043

$5,300
BUY NOW GET FREE SAMPLE